Joseph Mckinsey

By Codexis, Inc. Published: Tuesday, Mar. 8, 2011 – 5:11 am REDWOOD CITY, Calif., March 8, 2011 — /PRNewswire/ — Codexis, Inc. (Nasdaq: CDXS) today announced that Jacques Beaudry-Losique has joined the company as Vice President, Corporate Development and Strategy. Mr. Beaudry-Losique joins Codexis from the U.S. Department of Energy, and will be responsible for corporate strategic planning for Codexis’ bioindustrials businesses and directing the company’s government relations programs. He will report to Joseph Sarret, M.D., Chief Business Officer. “Jacques Beaudry-Losique brings Codexis broad knowledge of the clean energy sector and senior leadership experience in managing renewable energy programs for the U.S. government, as well as a depth of experience working with Fortune 500 corporations,” said Alan Shaw, Ph.D. President and Chief Executive Officer. “His extensive management and policy background will be vital to Codexis as we expand our business. We are very pleased to welcome him to our management team.” Mr. Beaudry-Losique has more than 20 years experience working in the energy and technology sectors. Most recently, he held senior policy and management positions at the Department of Energy for six years, from 2005 to 2011. Previously, he worked with and advised Fortune 500 companies while at McKinsey & Co. and in strategic planning and management roles at General Electric and Shell. While at DoE, he led efforts to build a second generation biofuels industry across two administrations, managed three major energy efficiency and renewable energy programs and served for two years as Deputy Assistant Secretary for Renewable Energy. He was also instrumental in decisions to invest more than $1.5 billion of Recovery Act funds in renewable energy projects, including $800 million in biofuels projects – as well as the project selection, tracking and management of many of these programs. Prior to joining DoE, Mr. Beaudry-Losique held key engineerin

http://www.sacbee.com/2011/03/08/3458034/codexis-names-jacques-beaudry.html By Codexis, Inc. Published: Tuesday, Mar. 8, 2011 – 5:11 am REDWOOD CITY, Calif., March 8, 2011 — /PRNewswire/ — Codexis, Inc. (Nasdaq: CDXS) today announced that Jacques Beaudry-Losique has joined the company as Vice President, Corporate Development and Strategy. Mr. Beaudry-Losique joins Codexis from the U.S. Department of Energy, and will be responsible for corporate strategic planning for Codexis’ bioindustrials businesses and directing the company’s government relations programs. He will report to Joseph Sarret, M.D., Chief Business Officer. “Jacques Beaudry-Losique brings Codexis broad knowledge of the clean energy sector and senior leadership experience in managing renewable energy programs for the U.S. government, as well as a depth of experience working with Fortune 500 corporations,” said Alan Shaw, Ph.D. President and Chief Executive Officer. “His extensive management and policy background will be vital to Codexis as we expand our business. We are very pleased to welcome him to our management team.” Mr. Beaudry-Losique has more than 20 years experience working in the energy and technology sectors. Most recently, he held senior policy and management positions at the Department of Energy for six years, from 2005 to 2011. Previously, he worked with and advised Fortune 500 companies while at McKinsey & Co. and in strategic planning and management roles at General Electric and Shell. While at DoE, he led efforts to build a second generation biofuels industry across two administrations, managed three major energy efficiency and renewable energy programs and served for two years as Deputy Assistant Secretary for Renewable Energy. He was also instrumental in decisions to invest more than $1.5 billion of Recovery Act funds in renewable energy projects, including $800 million in biofuels projects – as well as the project selection, tracking and management of many of

"You have to be able to function at work in recovery," said Joe McKinsey, founder of the Dunes East Hampton, a New York-based addiction treatment center that serves many executives and "Wall Street guys," in McKinsey's words. Patients at the ...

"It's an astounding amount of decay," said Dr. Joseph Greene, a pediatric dentist in Harrisonburg ... It's also been tough for 12-year old McKinsey Estes of Waynesboro. "Last year she started complaining of pain on the left side of her face.

But since then, I've learned about something even worse, from a startling new study by Greenpeace entitled Bad Influence: How McKinsey-insipred plans lead ... of the sum that Nobel Prize-winning economist Joseph Stiglitz calculated was the long-term ...

As a recent article in McKinsey Quarterly notes ... we’re starting to see today but will definitely be common in the next few years. Here goes: “Joe” just got a cool new “3D projection entertainer”.  But when the excitement of unpacking and ...

McKinsey’s conclusions seem accurate ... The plaintiff in this case is Yevgeny Dzhugashvili, the grandson of Joseph Stalin. Dzhugashvili claims that during a conference on the Nuremberg Trials and modern day falsifications of WWII history, held in ...

Those who voted for the override include: David Testa, D-2, Rocco Giruzzi, R-3, Joseph Marino, D-4, Jerome McKinsey, D-5, Samantha Colosimo-Testa, R-6, Frank Meola, D-at-large, and Edward Bucciero, D-at-large. Those who voted against include Frank Vescera ...

“After meeting with Joe and the rest of the team ... securities trading and financial engineering at Lehman Brothers, and was an associate at McKinsey & Co. Collective has made significant strides in becoming a scalable business that can ...

And McKinsey said Chinese traditions of thrift and caution would ... The Obama administration welcomed the swift congressional approval. Vice President Joe Biden said in a statement that Congress "has taken a clear stand against the unfair trade practices ...

FORCE Therapeutics has raised seed funding from prominent CEO investors including Thomas Layton, John Pleasants, Joseph Varet ... was an associate principal at McKinsey, and previously worked with Johnson & Johnson’s leading strategy and ...

Though it hasn’t recommended some purse funds be allocated to marketing and drug testing, The Jockey Club is investing more than $10 million on a Thoroughbred awareness campaign based on 2011 recommendations from McKinsey and Company.